Home » Stocks » Cardiovascular Systems

Cardiovascular Systems, Inc. (CSII)

Stock Price: $31.11 USD 0.20 (0.65%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.23B
Revenue (ttm) 236.54M
Net Income (ttm) -10.60M
Shares Out 39.50M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $31.11
Previous Close $30.91
Change ($) 0.20
Change (%) 0.65%
Day's Open 30.62
Day's Range 30.62 - 31.74
Day's Volume 187,787
52-Week Range 26.00 - 55.22

More Stats

Market Cap 1.23B
Enterprise Value 1.14B
Earnings Date (est) Oct 21, 2020
Ex-Dividend Date n/a
Shares Outstanding 39.50M
Float 33.99M
EPS (basic) -0.31
EPS (diluted) -0.80
FCF / Share 0.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.11%
Payout Ratio n/a
Shares Short 1.29M
Short Ratio 3.15
Short % of Float 4.19%
Beta 1.40
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 904.28
PS Ratio 5.20
PB Ratio 8.48
Revenue 236.54M
Operating Income -10.79M
Net Income -10.60M
Free Cash Flow 1.36M
Net Cash 86.39M
Net Cash / Share 2.19
Gross Margin 79.39%
Operating Margin -4.56%
Profit Margin -4.00%
FCF Margin 0.57%
ROA -6.00%
ROE -13.07%
ROIC -7.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (11)

Buy 7
Overweight 0
Hold 3
Underweight 1
Sell 0

Analyst Consensus: Buy

Price Target

$43.78*
(40.73% upside)
Low
38.0
Current: $31.11
High
50.0
Target: 43.78
*Average 12-month price target from 9 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue24821720517818213710482.4978.7864.83
Revenue Growth14.27%5.92%15%-1.85%32.89%31.49%25.95%4.71%21.52%-
Gross Profit20017816514314210679.5263.2762.5049.83
Operating Income-0.832.23-1.54-56.08-32.64-33.49-22.42-14.47-8.81-22.90
Net Income-0.261.71-1.79-56.02-32.82-35.29-24.04-16.79-11.13-23.90
Shares Outstanding33.5433.1532.3732.5431.5528.3021.6918.0415.9214.75
Earnings Per Share-0.010.05-0.06-1.72-1.04-1.25-1.11-0.93-0.70-1.62
Operating Cash Flow10.219.6719.59-23.58-22.36-26.84-10.77-11.34-8.36-13.57
Capital Expenditures-2.67-1.96-0.98-3.82-20.33-12.72-1.67-0.44-1.08-0.79
Free Cash Flow7.547.7218.61-27.40-42.68-39.56-12.44-11.78-9.44-14.36
Cash & Equivalents12311710961.3285.7212767.9035.5321.1623.72
Total Debt20.9721.0621.10--2.4012.5717.5212.1411.29
Net Cash / Debt10295.7487.5261.3285.7212455.3318.019.0212.43
Assets21920319414217118296.9063.1246.7642.72
Liabilities70.6368.8875.5541.5131.8929.8530.0730.9425.1225.01
Book Value14813411810113915266.8332.1921.6417.72
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cardiovascular Systems, Inc.
Country United States
CEO Scott R. Ward

Stock Information

Ticker Symbol CSII
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: CSII
IPO Date February 26, 2009

Description

Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary OAS, a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.